Cowen And Company »

Crixus Bh3 Acquisition Co Class A shares owned by Cowen And Company

Quarter-by-quarter ownership of Crixus Bh3 Acquisition Co Class A (BHAC) shares owned by Cowen And Company from 13F filings

Historical chart of Cowen And Company investment in Crixus Bh3 Acquisition Co Class A

Tip: Access up to 7 years of quarterly data

All positions including Crixus Bh3 Acquisition Co Class A held by Cowen And Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crixus Bh3 Acquisition Co Class A by Cowen And Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $785k 75k 10.46
2022-03-31 $4.1M 413k 9.85
2021-12-31 $4.1M 423k 9.80

More positions owned by Cowen And Company

NVIDIA Corporation (NVDA)
Ptc Therapeutics I (PTCT)
Coinbase Global Com Cl A (COIN)
Avidity Biosciences Ord (RNA)
Sirius Xm Holdings (SIRI)
Tarsus Pharmaceuticals (TARS)
Churchill Capital Corp Vii Com Cl A (CVII)
Immunocore Hldgs Ads (IMCR)
Select Sector Spdr Tr Energy (XLE)
Rocket Pharmaceuticals (RCKT)
Mercer International (MERC)
Screaming Eagle Acquisitn Class A Ord Shs (SCRM)
Sage Therapeutics (SAGE)
Alibaba Group Hldg Sponsored Ads (BABA)
Imperial Oil Com New (IMO)

View all positions for Cowen And Company

Top funds holding Crixus Bh3 Acquisition Co Class A

Polar Securities
Exos TFP Holdings
Sea Otter Advisors
CNH Partners
Sandia Investment Management
K2 Principal Fund
Cowen And Company
Quarry
Walleye Trading Advisors
Walleye Trading
Tuttle Tactical Management
Virtu Financial
Robinson Capital Management
Flow Traders US

View all funds holding Crixus Bh3 Acquisition Co Class A